findmyKOL

Stephen Smith, MD

Basic profile

Johns Hopkins University

ORCIDNone on fileNPI↗
✓ Full record
RegionBaltimore, MD · NortheastSpecialtyEndocrinology, Diabetes & MetabolismFocusEndocrinology/Metabolic
Last active 2023findmyKOL type: RegionalLatest publication2023Online presenceNot yet checkedPayments2021 onwardNIH funding1988–2014Why? →

Stephen Smith is an Endocrinology/Metabolic physician affiliated with Johns Hopkins University. OpenAlex indexes 5 publications with 252 citations (h-index 2).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
5publications

Distinct works indexed by OpenAlex.

252citations

Total citations across indexed works.

2h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
10companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
5NIH grants · 1988–2014

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

8709 Harford Road
Baltimore, MD 21234

Telephone

410-882-4741

Registry record last updated 8 Jul 2007.

View the NPPES registry record

Industry payments

10 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2022)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    51%
    Statin15.9%
    Simvastatin66%Atorvastatin Calcium34%
    Part D≥24 patients
    Calcium channel blocker9.2%
    Amlodipine Besylate100%
    Part D≥25 patients

    + 6 more classes in this area

  • Metabolism & gastrointestinal

    25.3%
    Biguanide (metformin)7.3%
    Metformin Hcl51%Metformin Hcl Er49%
    Part D<11 patients
    Proton pump inhibitor4.8%
    Omeprazole100%
    Part D≥14 patients

    + 4 more classes in this area

  • Nervous system

    9.4%
    Gabapentinoids5.3%
    Gabapentin100%
    Part D<11 patients
    SSRI2.2%
    Trazodone Hcl100%
    Part D<11 patients

    + 1 more class in this area

Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

5 NIH research awards on record, funded 1988–2014 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”